Can single-patient investigational new drug studies hurry slow trains to the fast track?
Tips from an Irish playwright and a Finnish oncologist could help the United States' National Cancer Institute reach its 2015 goal.
Dale
D
Chenoweth
D000970:Antineoplastic Agents / Q000627:therapeutic use; D002986:Clinical Trials as Topic / Q000379:methods*; D017277:Drug Approval / Q000458:organization & administration*; D015507:Drugs, Investigational / Q000627:therapeutic use*; D006801:Humans; D009316:National Institutes of Health (U.S.); D009369:Neoplasms / Q000188:drug therapy; D018579:Patient Selection; D014481:United States; D014486:United States Food and Drug Administration
D000970:Antineoplastic Agents; D015507:Drugs, Investigational